AstraZeneca Pharmaceuticals, LP

Form 483

Newark, Delaware, United StatesFEI 2517100Issued August 27, 2014

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2517100.

Observations1

Issue DateAugust 27, 2014

StatusNo Warning Letter

Related Inspections7

Establishment Details

Firm: AstraZeneca Pharmaceuticals, LP
Location: Newark, Delaware, United States
FEI Number: 2517100
Product Type: Drugs
Issue Date: August 27, 2014
Country: United States

Inspection History, 2009 to 2026

NAI3

VAI4

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

AstraZeneca Pharmaceuticals, LP FDA Form 483, Newark, Delaware, August 27, 2014